Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2010
07/14/2010EP1539141B1 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
07/14/2010EP1486494B1 N-substituted benzothiophenesulfonamide derivative
07/14/2010CN1914170B Synthetic methodology for the reductive alkylation at the c-3 position of indoles
07/14/2010CN1823063B Quinoline derivatives as phosphodiesterase inhibitors
07/14/2010CN101778905A Indolium compound and optical recording material using the compound
07/14/2010CN101778845A Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives
07/14/2010CN101778844A Dual modulators of 5-ht2a and d3 receptors
07/14/2010CN101778833A Nitrogen-containing heterocyclic compound and pest control agent
07/14/2010CN101778831A Novel piperazine amide derivatives
07/14/2010CN101775013A Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
07/14/2010CN101774979A Class of aryl-acrylketone compound containing 1,3,5-dioxazine heterocycle, preparation method and application thereof
07/14/2010CN101774976A Sulfonyl isoxazoline derivative and anti-tumor application
07/13/2010US7754892 Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
07/13/2010US7754891 5,5′-Position linked 1,1′-biphenyl axial chiral ligand and method for preparing the same
07/13/2010US7754880 enhanced characteristics in terms of herbicidal activity with respect to weeds and/or in terms of lower phytotoxicity for crops of agricultural interest; methyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate
07/13/2010US7754756 N-(1-{3-[(R)-2-[3-(phenylsulphonylamino)-phenyl]-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-indol-5-yl)-2-cyano-acetamide, used for treating non-insulin dependent diabetes, obesity or overactive bladder
07/13/2010US7754746 3-{3-[5-(4-acetylphenyl)-4-methylthiazol-2-yl]-ureido}-N-tert-butylpropionamide, exhibiting phosphatidylinositol 3-kinase inhibitory activity and used for treating respiratory system disorders, such as asthma
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754741 nonphytotoxic of N-[2-(3-Chloro-5-trifluoromethyl-pyridin-2-yl) ethyl]-2-trifluoromethyl-nicotinamide, used for controlling phytopathogenic fungi selected from Alternaria and Pyrenophora
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
07/13/2010US7754726 Benzamide derivatives as p-38 kinase inhibitors
07/13/2010US7754723 Therapeutic agents useful for treating pain
07/13/2010US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
07/13/2010US7754714 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers
07/13/2010US7754713 such as 6-(4-Hydroxy-3,5-dimethylphenyl)-4-(7-methyl-1H-benzimidazol-2-yl)-2H-pyridazin-3-one, used as cyclin-dependent kinase inhibitors, for the treatment of cancer, in particular solid tumors or leukemia; anticarcinogenic agents
07/13/2010CA2432211C Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
07/08/2010WO2010078408A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010WO2010078369A2 Pyrimidinediamine kinase inhibitors
07/08/2010WO2010078103A1 Modulators of cystic fibrosis transmembrane conductance regulator
07/08/2010WO2010077992A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/08/2010WO2010077882A2 Antagonists of lysophosphatidic acid receptors
07/08/2010WO2010077101A2 Novel thiazolidinedione derivative and use thereof
07/08/2010WO2010076810A2 A process for the preparation of gefitinib
07/08/2010WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors
07/08/2010WO2010075957A1 Substituted furancarboxamides, and use thereof
07/08/2010WO2010075631A1 Polymorphic form of 5-chloro-n-{[(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl}thiophene-2-carboxamide
07/08/2010WO2010055164A3 Isoquinolone derivatives as inhibitors of plavivirus replication
07/08/2010WO2009143039A3 Heterocyclic compounds as factor ixa inhibitors
07/08/2010US20100174065 Compounds
07/08/2010US20100173949 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173910 Triaminopyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
07/08/2010US20100173908 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
07/08/2010US20100173905 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
07/08/2010US20100173901 Substituted Heterocyclic Compounds
07/08/2010US20100173899 Dipeptide analogs as coagulation factor inhibitors
07/08/2010US20100173898 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
07/08/2010US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/08/2010US20100173888 Nicotinamide Derivatives
07/08/2010US20100173886 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
07/08/2010US20100173413 Pyridine compounds
07/08/2010CA2748853A1 Polymorphic form of 5-chloro-n-{[(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl}thiophene-2-carboxamide
07/08/2010CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010CA2747640A1 Substituted furancarboxamides, and use thereof
07/08/2010CA2746810A1 Pyrimidinediamine kinase inhibitors
07/08/2010CA2746307A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/07/2010EP2203447A1 Inhibitors of the interaction between mdm2 and p53
07/07/2010EP2203446A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition
07/07/2010EP2203445A1 Azabicyclo ý3. 1. o¨hexyl derivatives as modulators of dopamine d3 receptors
07/07/2010EP2203438A1 Cyanoisoquinoline
07/07/2010EP2203431A1 Anti-infective pyrimidines and uses thereof
07/07/2010EP2203430A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
07/07/2010EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
07/07/2010EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
07/07/2010EP1873153B1 3-azetidinecarboxylic acid derivatives for use as immunosuppressants
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN101772497A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate
07/07/2010CN101772495A fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
07/07/2010CN101772493A gamma secretase modulators
07/07/2010CN101768155A Derivatives containing (aminomethyl-five-membered heterocyclo-4-carbonyl)-pyrrolidine-2-carboxylic acid, preparation method thereof and use thereof
07/07/2010CN101768154A New preparation method of iloperidone
07/07/2010CN101768153A Method for preparing israbipine medicament for treating hypertension
07/07/2010CN101768145A Nitric oxide-donating chrysin derivatives, preparation method thereof, medical use thereof
07/07/2010CN101768138A Organic micro-molecular film containing protonized nitrogen atoms and preparation method thereof
07/07/2010CN101768131A Method for hydrogenating o-nitryl phenoxyl carbonyl compound to prepare a derivative of benzo morpholines
07/07/2010CN101768129A Production intermediate of isoxazoline-substituted benzamide compound
07/06/2010USRE41425 Piperazine and piperidine compounds
07/06/2010US7750164 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
07/06/2010US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds
07/06/2010US7750154 Amide derivatives
07/06/2010US7750151 Inhibitors of Akt activity
07/06/2010US7750150 Process for producing acid adduct salt of polyacidic base compound
07/06/2010US7750032 Compounds and compositions as PPAR modulators
07/06/2010US7750026 N-Cyclopropyl-3-[5-fluoro-3-(4-pyridinyl)-1H-indazol-6-yl]-4-methylbenzamide, useful in the treatment of conditions or disease states mediated by p38 mitogen-activated protein kinase activity or mediated by cytokines produced by the activity of p38 mitogen-activated protein kinases
07/06/2010US7750012 leukotriene A4 hydrolase inhibitors such as 4-{4-[4-(4-Iodo-phenoxy)-phenyl]-piperazin-1-yl]-butyric acid methyl ester, used for the treatment, prevention and/or prophylaxis of inflammatory diseases and disorders
07/06/2010US7750007 Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
07/06/2010US7750006 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/06/2010US7750003 mammalian target of rapamysin (mTOR)/phosphatidylinositol (PI) kinase-related kinase (PIKK) family inhibitor; antiproliferative, anticarcinogenic, antiinflammation agent, immunostimulant;
07/06/2010US7750002 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders
07/06/2010US7750001 2-(2-methylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine; phosphatidylinositol 3-kinase (PI3K) inhibitor; transplantation of organs or tissues, inflammatory bowel diseases, psoriasis or atopic dermatitis, chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, scleroderma
07/06/2010US7750000 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
07/06/2010US7749998 urotensin antagonists such as N-[1-(4-biphenyl)-1)-2-(1-pyrrolidinyl)ethyl]-2-(6,7-dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-N-methylacetamide, used for treating congestive heart failure, stroke, ischemia, angina, overactive bladder or arrhythmia
07/06/2010US7749996 Heterotricyclic metalloprotease inhibitors
07/06/2010US7749995 modulator of cholesteryl ester transfer protein (CETP), such as 1,1,1-Trifluoro-3-[3-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-8-(3-trifluoromethoxy-phenyl)-2,3-dihydro-benzo[1,4]oxazin-4-yl]-propan-2-ol, used for treating cardiovascular disorders, dyslipidemia, and metabolic disorders
07/06/2010US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
07/06/2010CA2382129C Novel derivatives of flavones, xanthones and coumarins
07/06/2010CA2177858C Benzimidazole derivatives, their preparation and their therapeutic use
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 647